Mereo BioPharma Group plc (MPH.L) (LON:MPH) Shares Down 1.9% – Here’s Why

Shares of Mereo BioPharma Group plc (MPH.L) (LON:MPH) fell 1.9% during mid-day trading on Monday . The stock traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.33). 49,264 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).

Mereo BioPharma Group plc (MPH.L) Trading Down 1.9 %

The firm has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The company has a fifty day moving average price of GBX 26.50 and a 200-day moving average price of GBX 26.50. The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26.

Mereo BioPharma Group plc (MPH.L) Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.